Review highlights mitochondrial dysfunction in cholestatic liver injury

Bile acids are essential signaling molecules derived from cholesterol metabolism in the liver and are crucial for the digestion and absorption of fats.

Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024 – Biotech Investments

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): 9 Month figures/Quarter Results Drägerwerk AG & Co. KGaA: Dräger with good demand, robust net sales

October 30, 2024

Promising new approach to treating type 2 diabetes

An estimated 462 million people around the world suffer from Type 2 diabetes, a chronic disease in which the body has problems using sugar as

August 23, 2024

TherageniX and University of Nottingham awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

Funding from Innovate UK’s Transforming Medicines Manufacturing program supporting innovative technologies for intracellular drug delivery.

September 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.